Ranolazine Extended-Release Tablets 500mg recall: Failed Dissolution
Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2, Phase-2…
Why was Ranolazine Extended-Release Tablets 500mg recalled?
Failed Dissolution Specifications: Out of specification for dissolution.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 17230388, Exp. 01/31/2025
- Product
- Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2, Phase-2…
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Quantity
- 16,944 bottles
- Distribution
- Nationwide
- Recall date
- November 15, 2023
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)